These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 14513254)
41. Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy. Jensen SL; Holmes R J Drugs Dermatol; 2003 Oct; 2(5):554-6. PubMed ID: 14558405 [TBL] [Abstract][Full Text] [Related]
42. Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Kartal ED; Alpat SN; Ozgunes I; Usluer G Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):817-20. PubMed ID: 17700271 [TBL] [Abstract][Full Text] [Related]
43. Dimorphic exanthema manifested as reticular maculopapular exanthema and erythema multiforme major associated with pyrazolon derivatives. Chen W; Hsieh FS Eur J Dermatol; 2002; 12(5):488-90. PubMed ID: 12370143 [TBL] [Abstract][Full Text] [Related]
44. [Intertriginous rash caused by pegylated liposomal doxorubicin]. Monteagudo B; Afonso-Afonso FJ; Cabanillas M; Used-Aznar MM Actas Dermosifiliogr; 2009 Apr; 100(3):241-2. PubMed ID: 19457315 [No Abstract] [Full Text] [Related]
45. Efonidipine-Induced Exanthematic Drug Eruption and Literature Review. Davis S; Raju AR; Thomas E; Cherian JJ J Cardiovasc Pharmacol; 2019 Jun; 73(6):394-396. PubMed ID: 31162248 [TBL] [Abstract][Full Text] [Related]
46. Cutaneous necrosis complicating the injection of pegylated interferon alpha-2b in a patient with chronic hepatitis C. Rosina P; Girolomoni G Acta Dermatovenerol Croat; 2008; 16(1):35-7. PubMed ID: 18358108 [TBL] [Abstract][Full Text] [Related]
47. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection. Girard C; Bessis D; Blatìre V; Guilhou JJ; Guillot B Br J Dermatol; 2005 Jan; 152(1):182-3. PubMed ID: 15656829 [No Abstract] [Full Text] [Related]
48. A longitudinal cohort study of mucocutaneous drug eruptions during interferon and ribavirin treatment of hepatitis C. Tavakoli-Tabasi S; Bagree A J Clin Gastroenterol; 2012 Feb; 46(2):162-7. PubMed ID: 21814144 [TBL] [Abstract][Full Text] [Related]
51. [Fatal Outcome for subcutaneous administration of Pegylated IFN alpha 2b in a man with Chronic C hepatitis under treatment with traditional bitherapy]. Domínguez Gozalo A; Hidalgo Correas FJ; García Benayas E; García Díaz B Farm Hosp; 2015 May; 39(3):186-8. PubMed ID: 26005896 [No Abstract] [Full Text] [Related]